These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1007 related articles for article (PubMed ID: 12523884)

  • 1. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.
    Leske MC; Heijl A; Hussein M; Bengtsson B; Hyman L; Komaroff E;
    Arch Ophthalmol; 2003 Jan; 121(1):48-56. PubMed ID: 12523884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of long-term progression in the early manifest glaucoma trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Dong L; Yang Z;
    Ophthalmology; 2007 Nov; 114(11):1965-72. PubMed ID: 17628686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors for progression and glaucoma treatment: the Early Manifest Glaucoma Trial.
    Leske MC; Heijl A; Hyman L; Bengtsson B; Komaroff E
    Curr Opin Ophthalmol; 2004 Apr; 15(2):102-6. PubMed ID: 15021220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Bengtsson B; Hyman L; Bengtsson B; Hussein M;
    Arch Ophthalmol; 2002 Oct; 120(10):1268-79. PubMed ID: 12365904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Manifest Glaucoma Trial: design and baseline data.
    Leske MC; Heijl A; Hyman L; Bengtsson B
    Ophthalmology; 1999 Nov; 106(11):2144-53. PubMed ID: 10571351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disc hemorrhages and treatment in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Yang Z; Heijl A;
    Ophthalmology; 2008 Nov; 115(11):2044-8. PubMed ID: 18692244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluctuation of intraocular pressure and glaucoma progression in the early manifest glaucoma trial.
    Bengtsson B; Leske MC; Hyman L; Heijl A;
    Ophthalmology; 2007 Feb; 114(2):205-9. PubMed ID: 17097736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Hyman L; Yang Z; Bengtsson B;
    Acta Ophthalmol; 2011 Dec; 89(8):749-54. PubMed ID: 20236252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of argon laser trabeculoplasty in the Early Manifest Glaucoma Trial.
    Heijl A; Peters D; Leske MC; Bengtsson B
    Am J Ophthalmol; 2011 Nov; 152(5):842-8. PubMed ID: 21843876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and vision-related quality of life in the early manifest glaucoma trial.
    Hyman LG; Komaroff E; Heijl A; Bengtsson B; Leske MC;
    Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early Manifest Glaucoma Trial update 2004].
    Erb C
    Ophthalmologe; 2005 Mar; 102(3):219-21. PubMed ID: 15700191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.
    Fontana H; Nouri-Mahdavi K; Lumba J; Ralli M; Caprioli J
    Ophthalmology; 2006 Jun; 113(6):930-6. PubMed ID: 16647135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Fellow Eye With Study Eye Disease Trajectories and Need for Fellow Eye Treatment in Collaborative Initial Glaucoma Treatment Study (CIGTS) Participants.
    Niziol LM; Gillespie BW; Musch DC
    JAMA Ophthalmol; 2018 Oct; 136(10):1149-1156. PubMed ID: 30098162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and Functional Progression in the Early Manifest Glaucoma Trial.
    Öhnell H; Heijl A; Brenner L; Anderson H; Bengtsson B
    Ophthalmology; 2016 Jun; 123(6):1173-80. PubMed ID: 26949119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study.
    Lindén C; Heijl A; Jóhannesson G; Aspberg J; Andersson Geimer S; Bengtsson B
    Acta Ophthalmol; 2018 Sep; 96(6):567-572. PubMed ID: 30242986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring visual field progression in the Early Manifest Glaucoma Trial.
    Heijl A; Leske MC; Bengtsson B; Bengtsson B; Hussein M;
    Acta Ophthalmol Scand; 2003 Jun; 81(3):286-93. PubMed ID: 12780410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective laser trabeculoplasty (SLT): 1-year results in early and advanced open angle glaucoma.
    Schlote T; Kynigopoulos M
    Int Ophthalmol; 2016 Feb; 36(1):55-61. PubMed ID: 25943174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
    Caprioli J; Coleman AL
    Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty.
    AGIS Investigators
    Am J Ophthalmol; 2002 Oct; 134(4):481-98. PubMed ID: 12383805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with intraocular pressure before and during 9 years of treatment in the Collaborative Initial Glaucoma Treatment Study.
    Musch DC; Gillespie BW; Niziol LM; Cashwell LF; Lichter PR;
    Ophthalmology; 2008 Jun; 115(6):927-33. PubMed ID: 17964655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.